Rivaroxaban dosing in patients with atrial fibrillation: results from the RIVER registry - is dosing according to renal function appropriate?

被引：0
|
作者：
Camm, A. J. [1 ]
Virdone, S. [2 ]
Fox, K. A. A. [3 ]
Pieper, K. S. [2 ]
Beyer-Westendorf, J. [4 ]
Le Heuzey, J. -Y. [5 ]
Haas, S. [6 ]
Kayani, G. [2 ]
Gersh, B. J. [7 ]
Turpie, A. G. G. [8 ]
Kakkar, A. K. [2 ,9 ]
机构：
[1] St Georges Uni, Cardiol Clin Acad Grp, Mol & Clin Sci Res Inst, London, England
[2] Thrombosis Res Inst, London, England
[3] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[4] Univ Hosp Carl Gustav Carus, Dept Med 1, Div Haematol, Thrombosis Res Unit, Dresden, Germany
[5] Rene Descartes Univ, Georges Pompidou Hosp, Paris, France
[6] Tech Univ Munich, Munich, Germany
[7] Mayo Clin, Coll Med, Rochester, MN USA
[8] McMaster Univ, Hamilton, ON, Canada
[9] UCL, London, England
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：558 / 558
页数：1
相关论文
共 50 条
  • [21] Characteristics of patients with atrial fibrillation treated with direct oral anticoagulants and new insights into inappropriate dosing: results from the French National Prospective Registry: PAFF
    Guenoun, Maxime
    Cohen, Serge
    Villaceque, Marc
    Sharareh, Ali
    Schwartz, Jerome
    Hoffman, Olivier
    Dib, Jean-Claude
    Ouazana, Leon
    Assouline, Serge
    Parrens, Eric
    Garban, Thierry
    Pradeau, Vincent
    Guedj-Meynier, Dominique
    Lequeux, Benoit
    Cohen, Charlotte
    Durand, Philippe
    Dievart, Francois
    Dhanjal, Tarvinder S.
    Sabouret, Pierre
    Lellouche, Nicolas
    EUROPACE, 2023, 25 (10):
  • [22] Modern warfarin-dosing algorithms in patients with atrial fibrillation
    Kolesnyk, M. Yu.
    Mykhaylovskyi, Ya. M.
    ZAPOROZHYE MEDICAL JOURNAL, 2015, (06) : 81 - 87
  • [23] Appropriate dosing of the individual direct oral anticoagulants in atrial fibrillation: Differences in the questions to be answered
    Rubboli, Andrea
    Morici, Nuccia
    Lip, Gregory Y. H.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 99 : 116 - 117
  • [24] WARFARIN DOSING IN PATIENTS WITH IMPAIRED RENAL FUNCTION
    Anderson, Aaron
    Limdi, Mohit
    Cavallari, Larisa
    Baird, Mellissa
    Allon, Michael
    Beasley, Mark
    Limdi, Nita
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) : A75 - A75
  • [25] Dosing of Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation and Renal Dysfunction
    Rymer, Jennifer A.
    Webb, Laura E.
    Wang, Tracy Y.
    CIRCULATION, 2021, 144
  • [26] Drug Dosing in Patients With Impaired Renal Function
    Brater, D. C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (05) : 483 - 489
  • [27] IMPROVING APPROPRIATE DOSING OF INTRAVENOUS DILTIAZEM IN PATIENTS WITH ATRIAL FIBRILLATION OR FLUTTER WITH RAPID VENTRICULAR RESPONSE IN THE EMERGENCY DEPARTMENT
    Pon, Gregory
    Pelsue, Brittany
    Gulbis, Brian
    JOURNAL OF EMERGENCY NURSING, 2020, 46 (02) : 246 - 253
  • [28] Appropriate dosing in patients with impaired renal function on medical wards before and after an educational intervention
    Baum, S.
    Harder, S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 (01) : 29 - 35
  • [29] Prescription of dabigatran and rivaroxaban at discharge for atrial fibrillation patients with different classes of renal function: Findings from the CCC-atrial fibrillation project
    Yang, Na
    Liu, Jing
    Liu, Jun
    Hao, Yongchen
    Smith, Sidney C., Jr.
    Huo, Yong
    Fonarow, Gregg C.
    Ge, Junbo
    Taubert, Kathryn A.
    Morgan, Louise
    Han, Yaling
    Ma, Changsheng
    Zhao, Dong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C137 - C137
  • [30] Rivaroxaban or Apixaban or Non-Valvular Atrial Fibrillation - Efficacy and Safety of Off-Label Under-Dosing According to Plasma Concentration
    Suwa, Michihiro
    Morii, Isao
    Kino, Masaya
    CIRCULATION JOURNAL, 2019, 83 (05) : 991 - +
12345